On the evening of August 30, American Health released its 2026 semi-annual report. The company achieved operating income of 3.844 billion yuan in the first half of the year, a year-on-year decrease of 6.45%; a net profit loss attributable to shareholders of listed companies was 182 million yuan, and a loss of 221 million yuan in the same period last year. Notably, the semi-annual report shows that as of June 30, Zhang Jianping and Fang Wenyan were not on the list of the company's top ten tradable shareholders. According to the American Health Quarterly Report, as of March 31, Zhang Jianping held 66.2574 million shares in the company, making him the company's tenth largest tradable shareholder; Zhang Jianping's affiliate Fang Wenyan held 127 million shares in the company, making him the company's third-largest tradable shareholder.

On the evening of August 30, American Health released its 2026 semi-annual report. The company achieved operating income of 3.844 billion yuan in the first half of the year, a year-on-year decrease of 6.45%; a net profit loss attributable to shareholders of listed companies was 182 million yuan, and a loss of 221 million yuan in the same period last year. Notably, the semi-annual report shows that as of June 30, Zhang Jianping and Fang Wenyan were not on the list of the company's top ten tradable shareholders. According to the American Health Quarterly Report, as of March 31, Zhang Jianping held 66.2574 million shares in the company, making him the company's tenth largest tradable shareholder; Zhang Jianping's affiliate Fang Wenyan held 127 million shares in the company, making him the company's third-largest tradable shareholder.